Disc Medicine, Inc.
IRON
Rank in Stocks
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Share Price
$75.39
Last synced: 2026-10-22
Market Cap
$2.89B
Change (1 day)
-0.80%
Change (1 year)
-9.92%
Country
US
Trade Disc Medicine, Inc. (IRON)
Category
Healthcare
Earnings for Disc Medicine, Inc. (IRON)
Earnings in Jun 2026 TTM: $-245.58M
According to Disc Medicine, Inc. latest financial reports the company's current earnings are $-245.58M. In 2024 the company made an earning of $-109.00M, a decrease compared to its 2023 earnings that were of $-76.33M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Disc Medicine, Inc. from 2020 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-245.58M | 15.94% |
| 2025 | $-211.82M | 94.33% |
| 2024 | $-109.00M | 42.80% |
| 2023 | $-76.33M | 63.00% |
| 2022 | $-46.83M | 30.19% |
| 2021 | $-35.97M | -11.92% |
| 2020 | $-40.84M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $5.27B | -2,247.95% |
US
|
|
| $-3.09B | 1,157.03% |
US
|
|
| $-4.02B | 1,535.41% |
AU
|
|
| $2.85B | -1,258.78% |
BE
|
|
| $1.95B | -894.31% |
NL
|
